关注
Louise emmett
Louise emmett
Professor of Medicine, University of New South Wales.
在 svha.org.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ...
The Lancet 397 (10276), 797-804, 2021
6432021
Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for …
JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ...
Journal of nuclear medicine 56 (8), 1185-1190, 2015
6412015
Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial
WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, ...
JAMA oncology 5 (6), 856-863, 2019
6032019
The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study
PJ Roach, R Francis, L Emmett, E Hsiao, A Kneebone, G Hruby, T Eade, ...
Journal of Nuclear Medicine 59 (1), 82-88, 2018
3782018
Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy
L Emmett, K Willowson, J Violet, J Shin, A Blanksby, J Lee
Journal of medical radiation sciences 64 (1), 52-60, 2017
3452017
Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
PJ van Leeuwen, L Emmett, B Ho, W Delprado, F Ting, Q Nguyen, ...
BJU international 119 (2), 209-215, 2017
3202017
68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
PJ van Leeuwen, P Stricker, G Hruby, A Kneebone, F Ting, B Thompson, ...
BJU international 117 (5), 732-739, 2016
3122016
E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET
F Ceci, DE Oprea-Lager, L Emmett, JA Adam, J Bomanji, J Czernin, ...
European journal of nuclear medicine and molecular imaging 48, 1626-1638, 2021
2492021
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the …
L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ...
European urology 80 (6), 682-689, 2021
2472021
Brown adipose tissue exhibits a glucose-responsive thermogenic biorhythm in humans
P Lee, R Bova, L Schofield, W Bryant, W Dieckmann, A Slattery, ...
Cell metabolism 23 (4), 602-609, 2016
1942016
Treatment outcomes from 68Ga-PSMA PET/CT–informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET
L Emmett, PJ van Leeuwen, R Nandurkar, MJ Scheltema, T Cusick, ...
Journal of Nuclear Medicine 58 (12), 1972-1976, 2017
1862017
Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen …
L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ...
Journal of Nuclear Medicine 60 (7), 950-954, 2019
1792019
Results of a prospective phase 2 pilot trial of 177Lu–PSMA-617 therapy for metastatic castration-resistant prostate cancer including imaging predictors of treatment response …
L Emmett, M Crumbaker, B Ho, K Willowson, P Eu, L Ratnayake, ...
Clinical genitourinary cancer 17 (1), 15-22, 2019
1662019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
GV Long, RPM Saw, S Lo, OE Nieweg, KF Shannon, M Gonzalez, ...
The Lancet Oncology 20 (7), 961-971, 2019
1572019
Reversible regional wall motion abnormalities on exercise technetium-99m–gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses
L Emmett, RM Iwanochko, MR Freeman, A Barolet, DS Lee, M Husain
Journal of the American College of Cardiology 39 (6), 991-998, 2002
1562002
FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma
AC Tan, L Emmett, S Lo, V Liu, R Kapoor, MS Carlino, AD Guminski, ...
Annals of Oncology 29 (10), 2115-2120, 2018
1442018
68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study
WP Fendler, J Calais, M Allen-Auerbach, C Bluemel, N Eberhardt, ...
Journal of Nuclear Medicine 58 (10), 1617-1623, 2017
1432017
A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC).
GV Long, V Atkinson, AM Menzies, S Lo, AD Guminski, MP Brown, ...
Journal of Clinical Oncology 35 (15_suppl), 9508-9508, 2017
1372017
TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer …
MS Hofman, L Emmett, J Violet, A Y. Zhang, NJ Lawrence, M Stockler, ...
BJU international 124, 5-13, 2019
1292019
Platelet activation in acute pulmonary embolism
T Chung, D Connor, J Joseph, L Emmett, R Mansberg, M Peters, D Ma, ...
Journal of Thrombosis and Haemostasis 5 (5), 918-924, 2007
1162007
系统目前无法执行此操作,请稍后再试。
文章 1–20